GoodRx (GDRX) CFO Justin Fengler Receives 48,532 Shares

What Happened

• Justin Fengler, GoodRx's Chief Financial Officer and Chief Strategy & Operations Officer, had multiple restricted stock unit (RSU) awards convert to common shares on August 15, 2026. A total of 48,532 shares were issued on conversion.
• To cover tax liabilities, 21,407 of those shares were withheld (tax withholding) at a price of $3.73 per share, generating approximately $79,848 in withholding. After withholding, Fengler retained a net 27,125 shares from these vesting events.
• Transaction codes: M = exercise/conversion of derivative (RSU → shares); F = payment of tax liability via share withholding. Some filing lines show $0.00 disposals related to the derivative conversions (conversion entries).

Key Details

• Transaction date: August 15, 2026; Form 4 filed August 17, 2026 (timely).
• Shares issued (conversion of RSUs): 48,532 total (10,149 + 6,423 + 6,392 + 25,568).
• Shares withheld for taxes: 21,407 total (withholding price reported at $3.73/share; total ≈ $79,848).
• Net shares retained from these vestings: 27,125.
• Footnotes: F1 indicates 1 RSU = 1 share. F2–F5 describe the original RSU grant vesting schedules (quarterly vesting dates for different grants).
• Filing status: timely (no late filing noted in the record provided).

Context

• This is a routine RSU vesting with shares withheld to satisfy tax obligations (common cashless withholding). It is not an open-market purchase or sale intended to express sentiment.
• For retail investors: vestings and tax-withholdings are expected administrative actions and do not necessarily signal the insider’s view of the company’s stock. M = conversion of derivative (here, RSUs); F = shares used to pay taxes.